News
Leukemia 360 organised by Carnot OPALE
LEUKEMIA 360 will be held on 13 November 2024 at the Centre de Conférence Pierre Mendès France organised bu Carnot OPALE.
Carnot for COSMETICS at COSMETIC 360 - Carnot STAR, 3BCAR and I2C
Carnot take part in LuxePack in Monaco
Carnot Chimie Balard Cirimat, Icéel, Ingénierie@Lyon, M.I.N.ES, MICA, are taking part in LuxePack 2024 on the 30th September to 2nd October 2024 on a joint stand.
VivaTech gives visibility to 22 exceptional start-ups powered by Carnot
The Carnot provide advanced technologies to more than 100 Deeptech start-ups per year.
Leti Innovation Days
LETI INNOVATION DAYS, JUNE 24-28 2019 : Deep Tech for edge artificial intelligence
Explore the power of distributed artificial intelligence, also called "Edge AI" during the Leti innovation Days on June 24-28, 2019 in Grenoble. Join to trigger the creative part of your brain and create your own innovation with AI now. Find out what's coming on the market within the next 10 years.
Cetim Carnot Institute : Fatigue Design 2019
Organized by Cetim Carnot Institute, the 8th Fatigue Design conference held in 2019 aims to present the most innovative approaches and scientific progress in design methodologies, tools, and equipment’s life extension, focusing on industrial applications.
For this edition, a new focus is made on the relation between additive manufacturing and fatigue.
Place : Senlis in France.
Date : From November 20, 2019 to November 21, 2019
The Leti Carnot Institute at SEMICON Europa 2016 in Grenoble
The Leti Carnot Institute will exhibit at SEMICON Europa 2016 in Grenoble, France, on Oct 25-27.
Learn more about the latest advancements in microelectronics with Leti experts as they discuss through a selection of conferences, forums and sessions.
Register now to download the full program and make the most of the largest microelectronics event in Europe!
CALYM’S 3rd SCIENTIFIC & PARTNERING DAY
CALYM’s 3rd SCIENTIFIC & PARTNERING DAY, will take place next October 17, 2016 in Paris, Espace Van Gogh, 62, quai de la Rapée.
CALYM researchers and clinicians will be happy to present the new lymphoma R&D offering and highlight research results of the consortium, from new therapeutic targets identification to Phase III pivotal clinical trials and beyond.
IPSEN and CELGENE representatives will bring industry standpoint.